Several HLA types have been found to be associated with diseases and pharmacogenetics. At GenDx we believe that innovation is the key for more reliable and efficient disease association screenings.
This is why we put a lot of effort into the development of a new product: NGSgo® HLA-LinkX®. It is fully compatible with our NGSgo® HLA typing strategy and it will reduce your laboratory workload and will make your NGS runs more cost-effective.
You have an opportunity to become among the first users of NGSgo HLA-LinkX by participating in the Early Access Program and testing the product!